SITUATION: A large pharmaceutical client requested help from RMPDC in evaluating clinical trial data and determine why a drug was linked to a high number of adverse events.


SOLUTION: RMPDC’s adverse-event specialists conducted an exhaustive literature review on the drug, drug class and clinical trial conditions. We examined the methodology of the clinical trials and examined all possible outcomes.  We eventually concluded that a specific clinical trial design potentiated the likelihood of specific adverse events and recommended revising future study designs, thus saving the client headaches and speeding the clinical trial process.